Terms: = Uterine cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
53 results:
1. Combination of serum CST1 and he4 for early diagnosis of endometrial cancer.
Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
PeerJ; 2023; 11():e16424. PubMed ID: 38077439
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
3. Effects of coagulation function indicators and tumor markers on diagnosis and clinicopathological characteristics of endometrial cancer.
Li H; Liao H; Jing B; Wang Y
Int J Biol Markers; 2023 Dec; 38(3-4):214-222. PubMed ID: 37635376
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
Wu Q; Bai SN; Song LY; Wu WF; Han LN
Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
[TBL] [Abstract] [Full Text] [Related]
5. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
[TBL] [Abstract] [Full Text] [Related]
6. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker he4 to evaluate tumour grade and lymphovascular space invasion.
Yue XN; He XY; Wu JJ; Fan W; Zhang HJ; Wang CW
Clin Radiol; 2023 Aug; 78(8):e574-e581. PubMed ID: 37183140
[TBL] [Abstract] [Full Text] [Related]
7. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
8. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of he4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
10. Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical cancer.
Hwang WY; Suh DH; Kim K; Kim YB; No JH
Cancer Control; 2022; 29():10732748221097778. PubMed ID: 35506739
[TBL] [Abstract] [Full Text] [Related]
11. Application Value of Real-Time Ultrasonic Elastograph with Serum Human Epididymis Protein 4, Interleukin-33, and Carbohydrate Antigen 153 in diagnosis of Early Cervical cancer.
Guo M; Liang L; Wu L; Xie D; Li J
J Healthc Eng; 2022; 2022():4880874. PubMed ID: 35449844
[TBL] [Abstract] [Full Text] [Related]
12. Endometriosis in para-aortic lymph node resembling a malignancy: a case report and literature review.
Li J; Liu Y; Du K; Xiao L; He X; Dai F; Tang J
BMC Womens Health; 2022 Apr; 22(1):101. PubMed ID: 35379213
[TBL] [Abstract] [Full Text] [Related]
13. Serum he4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
[TBL] [Abstract] [Full Text] [Related]
14. The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate.
Liu J; Han L; Jiao Z
Sci Rep; 2021 Jan; 11(1):575. PubMed ID: 33436780
[TBL] [Abstract] [Full Text] [Related]
15. Endometrial cancer: A systematic review of he4, REM and REM-B.
Degez M; Caillon H; Chauviré-Drouard A; Leroy M; Lair D; Winer N; Thubert T; Dochez V
Clin Chim Acta; 2021 Apr; 515():27-36. PubMed ID: 33388311
[TBL] [Abstract] [Full Text] [Related]
16. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer.
Yang D; Li H; Sun X; Yang S; Wang K; Liu Z
Sci Rep; 2020 Nov; 10(1):20056. PubMed ID: 33208875
[TBL] [Abstract] [Full Text] [Related]
17. Meta-analysis of the diagnostic accuracy of he4 for endometrial carcinoma.
Liu J; Han L; Sun Q; Li Y; Niyazi M
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
[TBL] [Abstract] [Full Text] [Related]
18. A New Risk Index Combining d-Dimer, Fibrinogen, he4, and CA199 Differentiates Suspecting Endometrial cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract] [Full Text] [Related]
19. Role of serum he4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract] [Full Text] [Related]
20. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma diagnosis: A Meta-Analysis and Systematic Review.
Huang GQ; Xi YY; Zhang CJ; Jiang X
Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
[No Abstract] [Full Text] [Related]
[Next]
